2017 is going to be a good year
Nusinersen is going to ramp for type 1 SMA and we should be on our way for TYPE2,3 approval. I agree with your comments on ApoC3
Sentiment: Strong Buy
yup margin calls
hope they talk about this promising technology at R&D day
Time Magazine has a tech article on this subject
What assets does IONIS have in this space. Technology? IP?
Phase 2b for its cancer drugs